相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives
Niranjan G. Kotla et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis
Sophie E. Berends et al.
CLINICAL PHARMACOKINETICS (2019)
MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice
Yuhua Tian et al.
GASTROENTEROLOGY (2019)
Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease
Mahira Zeeshan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Orally Delivered Antisense Oligodeoxyribonucleotides of TNF-α via Polysaccharide-Based Nanocomposites Targeting Intestinal Inflammation
Bingchao Duan et al.
ADVANCED HEALTHCARE MATERIALS (2019)
The biology of mucus: Composition, synthesis and organization
Rama Bansil et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Redox-sensitive nanoparticles based on 4-aminothiophenol-carboxymethyl inulin conjugate for budesonide delivery in inflammatory bowel diseases
Qijuan Sun et al.
CARBOHYDRATE POLYMERS (2018)
Rational Design of Polyphenol-Poloxamer Nanovesicles for Targeting Inflammatory Bowel Disease Therapy
Xinyu Wang et al.
CHEMISTRY OF MATERIALS (2018)
Inflamed site-specific drug delivery system based on the interaction of human serum albumin nanoparticles with myeloperoxidase in a murine model of experimental colitis
Yasunori Iwao et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Surface modification with polyethylene glycol enhances colorectal distribution and retention of nanoparticles
Rute Nunes et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Colon-targeted delivery of cyclosporine A using dual-functional Eudragit (R) FS30D/PLGA nanoparticles ameliorates murine experimental colitis
Muhammad Naeem et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Self-assembling polymeric nanocarriers to target inflammatory lesions in ulcerative colitis
Herve Courthion et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
Susan Hua et al.
FRONTIERS IN PHARMACOLOGY (2018)
Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine
Wei Li et al.
BIOMATERIALS (2018)
Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease
Abhijit A. Date et al.
BIOMATERIALS (2018)
Local delivery of macromolecules to treat diseases associated with the colon
A. Bak et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
pH and Reactive Oxygen Species-Sequential Responsive Nano-in-Micro Composite for Targeted Therapy of Inflammatory Bowel Disease
Serena Bertoni et al.
ADVANCED FUNCTIONAL MATERIALS (2018)
Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-α siRNA provide a novel strategy for the experimental treatment of ulcerative colitis
Yuzhe Huang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Rectal administration of nanosystems: from drug delivery to diagnostics
Melanie Melo et al.
MATERIALS TODAY CHEMISTRY (2018)
Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model
Ana Melero et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
Gilaad G. Kaplan et al.
GASTROENTEROLOGY (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice
Haiying Tang et al.
MOLECULAR MEDICINE REPORTS (2017)
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis
Bo Xiao et al.
MOLECULAR THERAPY (2017)
Ultra-small solid archaeolipid nanoparticles for active targeting to macrophages of the inflamed mucosa
Leticia Herminia Higa et al.
NANOMEDICINE (2017)
Bifunctional Succinylated ε-Polylysine-Coated Mesoporous Silica Nanoparticles for pH-Responsive and Intracellular Drug Delivery Targeting the Colon
Chau T. H. Nguyen et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Electrospun pH-sensitive core shell polymer nanocomposites fabricated using a tri-axial process
Chen Yang et al.
ACTA BIOMATERIALIA (2016)
Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease
Melissa Guada et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo
Annika Frede et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Abhijit A. Date et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Theranostic Fibers for Simultaneous Imaging and Drug Delivery
Miao Jin et al.
MOLECULAR PHARMACEUTICS (2016)
Electrospun Contrast-Agent-Loaded Fibers for Colon-Targeted MRI
Miao Jin et al.
ADVANCED HEALTHCARE MATERIALS (2016)
A Mouse Intra-Intestinal Infusion Model and its Application to the Study of Nanoparticle Distribution
Ana Sadio et al.
FRONTIERS IN PHYSIOLOGY (2016)
Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse
Katharina Maisel et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles
Wenyue Cheng et al.
JOURNAL OF GENE MEDICINE (2015)
Drug delivery strategies in the therapy of inflammatory bowel disease
Christian Lautenschlaeger et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Nanomedicines: addressing the scientific and regulatory gap
Sally Tinkle et al.
ANNALS REPORTS (2014)
Enzyme/pH dual sensitive polymeric nanoparticles for targeted drug delivery to the inflamed colon
Muhammad Naeem et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
Nanoparticles With Surface Antibody Against CD98 and Carrying CD98 Small Interfering RNA Reduce Colitis in Mice
Bo Xiao et al.
GASTROENTEROLOGY (2014)
pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease
Ana Beloqui et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis
Hamed Laroui et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases
H. Ali et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Lectin-decorated nanoparticles enhance binding to the inflamed tissue in experimental colitis
Brice Moulari et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Targeting Intestinal Inflammation With CD98 siRNA/PEI-loaded Nanoparticles
Hamed Laroui et al.
MOLECULAR THERAPY (2014)
Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review
Alejandro Sosnik et al.
PROGRESS IN POLYMER SCIENCE (2014)
Harnessing Nanomedicine for Mucosal Theranostics-A Silver Bullet at Last?
Eran Elinav et al.
ACS NANO (2013)
Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract
Christina Kriegel et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy
Bo Xiao et al.
BIOMATERIALS (2013)
PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease
Christian Lautenschlaeger et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Drug delivery to inflamed colon by nanoparticles: Comparison of different strategies
Regis Coco et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa-A first in vivo study in human patients
Carsten Schmidt et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis
Hakan Alagozlu et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2013)
Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa
Eva-Maria Collnot et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Nanoparticle-based clodronate delivery mitigates murine experimental colitis
Wiebke Niebel et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale
Jose das Neves et al.
EXPERT OPINION ON DRUG DELIVERY (2011)
Altered O-glycosylation Profile of MUC2 Mucin Occurs in Active Ulcerative Colitis and Is Associated with Increased Inflammation
Jessica M. Holmen Larsson et al.
INFLAMMATORY BOWEL DISEASES (2011)
Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease
Christina Kriegel et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Genetics and pathogenesis of inflammatory bowel disease
Bernard Khor et al.
NATURE (2011)
Optimization of conventional therapy in patients with IBD
Kirstin M. Taylor et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease
Christina Kriegel et al.
Clinical and Translational Gastroenterology (2011)
Drug-Loaded Nanoparticles Targeted to the Colon With Polysaccharide Hydrogel Reduce Colitis in a Mouse Model
Hamed Laroui et al.
GASTROENTEROLOGY (2010)
Targeting delivery of anti-TNF alpha oligonucleotide into activated colonic macrophages protects against experimental colitis
Longsheng Zuo et al.
GUT (2010)
Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines
D. Scott Wilson et al.
NATURE MATERIALS (2010)
IBD Selective nanoparticle adhesion can enhance colitis therapy
Alf Lamprecht
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model
Abdallah Makhof et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Controlled Surface Modification with Poly(ethylene)glycol Enhances Diffusion of PLGA Nanoparticles in Human Cervical Mucus
Yen Cu et al.
MOLECULAR PHARMACEUTICS (2009)
Transferrin as a Luminal Target for Negatively Charged Liposomes in the Inflamed Colonic Mucosa
Boaz Tirosh et al.
MOLECULAR PHARMACEUTICS (2009)
Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract
Mayank D. Bhavsar et al.
AAPS PHARMSCITECH (2008)
The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis
Brice Moulari et al.
BIOMATERIALS (2008)
Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease
M. D. Bhavsar et al.
GENE THERAPY (2008)
Quality of life of patients with ulcerative colitis: Past, present, and future
E. Jan Irvine
INFLAMMATORY BOWEL DISEASES (2008)
Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease
V. Strugala et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Gut instincts: Explorations in intestinal physiology and drug delivery
Emma L. McConnell et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease
David Pertuit et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey
Subrata Ghosh et al.
JOURNAL OF CROHNS & COLITIS (2007)
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
Daniel N. Frank et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications
Joachim Mankertz et al.
CURRENT OPINION IN GASTROENTEROLOGY (2007)
Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS)
Mayank D. Bhavsar et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Samuel K. Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach
C Manichanh et al.
GUT (2006)
Budesonicle in the treatment of inflammatory bowel disease: The first year of experience in clinical practice
A Chopra et al.
INFLAMMATORY BOWEL DISEASES (2006)
State of the art: IBD therapy and clinical trials in IBD
KL Isaacs et al.
INFLAMMATORY BOWEL DISEASES (2005)
Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats
A Lamprecht et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Review article: monitoring of immunomodulators in inflammatory bowel disease
FN Aberra et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide
RN Fedorak et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Regulation of intestinal epithelial function: a link between opportunities for macromolecular drug delivery and inflammatory bowel disease
D Siccardi et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Review article: monitoring for drug side-effects in inflammatory bowel disease
RN Cunliffe et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Side effects of corticosteroid therapy
AL Buchman
JOURNAL OF CLINICAL GASTROENTEROLOGY (2001)
Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa
A Lamprecht et al.
PHARMACEUTICAL RESEARCH (2001)
Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs
SG Nugent et al.
GUT (2001)
Biomarkers of myeloperoxidase-derived hypochlorous acid
CC Winterbourn et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
分享论文
